Wayland Group announced that it has received both Good Manufacturing Practices and Good Distribution Practices certifications from the national authority in the State of Saxony for the Company's Ebersbach facility in Germany. Specifically, these certifications are for a 50,000 square foot area within Wayland's much larger facility located just outside of Dresden, Germany. This marks Wayland's second facility to receive the EU-GMP certification, the high standard of pharmaceutical production in the world. These certifications provide Wayland with the foundation to start selling product into the lucrative German and other developing European markets with drastically shorter lead times and greater margins. The company will also be able to store bulk product in Germany for sale into the German market, which should serve to eliminate the lengthy process involved in receiving individual export licenses. Selling directly into Germany will allow the Company to capture higher margins for their products as the market remains materially undersupplied.